Advertisement

Journal of NeuroVirology

, Volume 23, Issue 4, pp 640–641 | Cite as

Response to the letter to the editor by Andreas Sauerbrei on “Acyclovir resistance in herpes simplex type I encephalitis, a case report”

  • Erich SchmutzhardEmail author
  • Melanie Bergmann
  • Ronny Beer
  • Mario Kofler
  • Raimund Helbok
  • Bettina Pfausler
Letter to the Editor
  • 170 Downloads

Notes

Compliance with ethical standards

Conflict of interest

All authors declare that there is no conflict of interest.

References

  1. Andrei G, Snoeck R (2013) Herpes simplex virus drug-resistance: new mutations and insights. Curr Opin Infect Dis 26:551–560CrossRefPubMedGoogle Scholar
  2. Bergmann M, Beer R, Kofler M, Helbok R, Pfausler B, Schmutzhard E (2017) Acyclovir resistance in herpes simplex virus type I encephalitis: a case report. J Neurovirol 23(2):335–337CrossRefPubMedGoogle Scholar
  3. Chilukuri S, Rosen T (2003) Management of acyclovir-resistant herpes simplex virus. Dermatol Clin 21:311–320CrossRefPubMedGoogle Scholar
  4. Sköldenberg B, Forsgren M, Alestig K et al (1984) Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet 2(8405):707–711CrossRefPubMedGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2017

Authors and Affiliations

  1. 1.Department of Neurology, NICUMedical University InnsbruckInnsbruckAustria

Personalised recommendations